Cargando…

Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study

BACKGROUND: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons older than 50 years. The highest incidence rates of the disease have been reported in Scandinavian countries. Our objective was to determine the epidemiology of GCA in an expected high-incidence region during a...

Descripción completa

Detalles Bibliográficos
Autores principales: Brekke, L. K., Diamantopoulos, A. P., Fevang, B-T., Aβmus, J., Esperø, E., Gjesdal, C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732381/
https://www.ncbi.nlm.nih.gov/pubmed/29246164
http://dx.doi.org/10.1186/s13075-017-1479-6
_version_ 1783286683636072448
author Brekke, L. K.
Diamantopoulos, A. P.
Fevang, B-T.
Aβmus, J.
Esperø, E.
Gjesdal, C. G.
author_facet Brekke, L. K.
Diamantopoulos, A. P.
Fevang, B-T.
Aβmus, J.
Esperø, E.
Gjesdal, C. G.
author_sort Brekke, L. K.
collection PubMed
description BACKGROUND: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons older than 50 years. The highest incidence rates of the disease have been reported in Scandinavian countries. Our objective was to determine the epidemiology of GCA in an expected high-incidence region during a 41-year period. METHODS: This is a hospital-based, retrospective, cohort study. Patients diagnosed with GCA in Bergen health area during 1972–2012 were identified through computerized hospital records (n = 1341). Clinical information was extracted from patients’ medical journals, which were reviewed by a standardized method. We excluded patients if data were unavailable (n = 253), if the reviewing rheumatologist found GCA to be an implausible diagnosis (n = 207) or if the American College of Rheumatology (ACR) 1990 classification criteria for GCA were not fulfilled (n = 89). Descriptive methods were used to characterize the sample. Incidence was analyzed by graphical methods and Poisson regression. RESULTS: A total of 792 patients were included. The average annual cumulative incidence of GCA was 16.7 (95% CI 15.5-18.0) per 100,000 of the population ≥ 50 years old. The corresponding incidence for biopsy-verified GCA was 11.2 (95% CI 10.2–12.3). The annual cumulative incidence increased with time in the period 1972–1992 (relative risk (RR) 1.1, p < 0.001) but not in 1993–2012 (RR 1.0, p = 0.543). The incidence was higher in women compared to men (average annual incidence 37.7 (95% CI 35.8–39.6) vs. 14.3 (95% CI 13.2–15.5), p < 0.001) with women having a twofold to threefold higher incidence rate throughout the study period. Average annual incidence increased with age until the 7th decade of life in both sexes throughout the study period (2.8 (95% CI 2.3–3.3) for age <60, 15.5 (95% CI 14.4–16.8) for age 60–69, 34.5 (95% CI 32.8–36.4) for age 70–79 and 26.8 (95% CI 25.3-28.4) for age ≥80 years, p < 0.001 for all age adjustments). CONCLUSIONS: Our study confirms an incidence of GCA comparable to previous reports on Scandinavian populations. Our results show increasing incidence from 1972 through 1992, after which the incidence has levelled out. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1479-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5732381
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57323812017-12-21 Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study Brekke, L. K. Diamantopoulos, A. P. Fevang, B-T. Aβmus, J. Esperø, E. Gjesdal, C. G. Arthritis Res Ther Research Article BACKGROUND: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons older than 50 years. The highest incidence rates of the disease have been reported in Scandinavian countries. Our objective was to determine the epidemiology of GCA in an expected high-incidence region during a 41-year period. METHODS: This is a hospital-based, retrospective, cohort study. Patients diagnosed with GCA in Bergen health area during 1972–2012 were identified through computerized hospital records (n = 1341). Clinical information was extracted from patients’ medical journals, which were reviewed by a standardized method. We excluded patients if data were unavailable (n = 253), if the reviewing rheumatologist found GCA to be an implausible diagnosis (n = 207) or if the American College of Rheumatology (ACR) 1990 classification criteria for GCA were not fulfilled (n = 89). Descriptive methods were used to characterize the sample. Incidence was analyzed by graphical methods and Poisson regression. RESULTS: A total of 792 patients were included. The average annual cumulative incidence of GCA was 16.7 (95% CI 15.5-18.0) per 100,000 of the population ≥ 50 years old. The corresponding incidence for biopsy-verified GCA was 11.2 (95% CI 10.2–12.3). The annual cumulative incidence increased with time in the period 1972–1992 (relative risk (RR) 1.1, p < 0.001) but not in 1993–2012 (RR 1.0, p = 0.543). The incidence was higher in women compared to men (average annual incidence 37.7 (95% CI 35.8–39.6) vs. 14.3 (95% CI 13.2–15.5), p < 0.001) with women having a twofold to threefold higher incidence rate throughout the study period. Average annual incidence increased with age until the 7th decade of life in both sexes throughout the study period (2.8 (95% CI 2.3–3.3) for age <60, 15.5 (95% CI 14.4–16.8) for age 60–69, 34.5 (95% CI 32.8–36.4) for age 70–79 and 26.8 (95% CI 25.3-28.4) for age ≥80 years, p < 0.001 for all age adjustments). CONCLUSIONS: Our study confirms an incidence of GCA comparable to previous reports on Scandinavian populations. Our results show increasing incidence from 1972 through 1992, after which the incidence has levelled out. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1479-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-15 2017 /pmc/articles/PMC5732381/ /pubmed/29246164 http://dx.doi.org/10.1186/s13075-017-1479-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Brekke, L. K.
Diamantopoulos, A. P.
Fevang, B-T.
Aβmus, J.
Esperø, E.
Gjesdal, C. G.
Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
title Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
title_full Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
title_fullStr Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
title_full_unstemmed Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
title_short Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
title_sort incidence of giant cell arteritis in western norway 1972–2012: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732381/
https://www.ncbi.nlm.nih.gov/pubmed/29246164
http://dx.doi.org/10.1186/s13075-017-1479-6
work_keys_str_mv AT brekkelk incidenceofgiantcellarteritisinwesternnorway19722012aretrospectivecohortstudy
AT diamantopoulosap incidenceofgiantcellarteritisinwesternnorway19722012aretrospectivecohortstudy
AT fevangbt incidenceofgiantcellarteritisinwesternnorway19722012aretrospectivecohortstudy
AT abmusj incidenceofgiantcellarteritisinwesternnorway19722012aretrospectivecohortstudy
AT esperøe incidenceofgiantcellarteritisinwesternnorway19722012aretrospectivecohortstudy
AT gjesdalcg incidenceofgiantcellarteritisinwesternnorway19722012aretrospectivecohortstudy